Read our latest Press Releases below. If you would like more information about any of the stories mentioned, please contact our Press Office.
Bexleyheath resident to host eight-hour virtual concert for allergy charity
30 Jun 2020
For World Allergy Week (29 June – 5 July) musician and student Jack Schwab, 18, is getting ready to perform eight hours of live music in aid of the Anaphylaxis Campaign, a UK-wide charity that provides support for those at risk of severe allergic reactions and anaphylaxis. Jack has a severe allergy to nuts and first […]
Anaphylaxis Campaign announces new president
06 May 2020
The Anaphylaxis Campaign, a UK charity that supports the growing number of adults and children affected by severe allergies, has today (6 May 2020) announced its new president, former vice-president David Reading OBE. On 2 April, the charity was notified of the sad death of its Honorary President, Dr. Bill Frankland MBE, who had supported […]
Anaphylaxis Campaign welcomes new youth ambassador
28 Apr 2020
In the run-up to our annual Anaphylaxis Awareness Week (4 – 10 May), the Anaphylaxis Campaign would like to welcome our new youth ambassador Dan Kelly, founder of the ‘May Contain’ blog (Instagram @_maycontain) and podcast, who will be working with us to support and empower young people living with severe allergies. Young people are frequently recognised as being the most […]
The Anaphylaxis Campaign’s Anaphylaxis Awareness Week 2020
20 Apr 2020
The Anaphylaxis Campaign has announced that our annual Anaphylaxis Awareness Week will go ahead as planned, despite the current situation with the Covid-19 Pandemic. As the NHS is currently under huge pressure, we at the Anaphylaxis Campaign, a UK charity which provides support and information to individuals and families affected by severe allergies, have decided to […]
Food retailers urged to help those with food allergies amid coronavirus stockpiling
06 Apr 2020
As the Anaphylaxis Campaign continues to receive reports from the allergic community about the lack of availability of FreeFrom and alternative foods during the coronavirus pandemic, we are taking measures to address this issue. With healthcare under huge pressure due to the pandemic, the Campaign has been encouraging all those affected by allergies to stick […]
The FDF publishes guidance on ‘Allergen’-Free and Vegan Claims
20 Feb 2020
The Food and Drink Federation (FDF) has today published ‘FDF Guidance on ‘Allergen’-Free and Vegan Claims’. This UK guidance, supported by the Food Standards Agency, aims to inform both the wider food industry and consumers as to the difference between ‘allergen’-free claims (e.g. milk-free) and vegan claims. Each claim communicates to different consumer groups, with only […]
First Oral Immunotherapy Drug ‘Palforzia’ gets FDA Approval
03 Feb 2020
The Anaphylaxis Campaign is delighted to hear about the success of Aimmune Therapeutics, Inc. in the approval of their oral immunotherapy drug, Palforzia, by the US Food and Drug Administration (FDA). This is the first oral immunotherapy drug that has been approved by the FDA. It currently does not have license for use in the […]
Clinicians & Charities Call For Urgent Action to Keep Food Allergic Children Safe in School
29 Jan 2020
An editorial in the February edition of Clinical and Experimental Allergy (the official journal of the British Society of Allergy and Clinical Immunology) explores the current statutory guidance on the care of children with medical conditions in schools, and highlights the existing shortcomings in keeping pupils with food allergy safe. The Department for Education will […]
Round-up of allergy news in 2019
18 Dec 2019
In 2019 we’ve seen announcements of promising change in labelling legislation, as well as increasing concern over medicine shortages and rising allergy figures. This year the Anaphylaxis Campaign also celebrated its 25th Anniversary but we are always striving for new ways to help those living with severe allergies. Before heading into 2020, we’ve looked back over […]
25 Years – Offering Guidance for Families and Young People Living with Allergies
27 Nov 2019
Since the Anaphylaxis Campaign was founded 25 years ago, hospital admissions for children and young people has increased sharply, with latest figures from NHS Digital showing a 70% rise in children under 18 in the last five years. Although there is no single cause for the rising prevalence of allergy and numerous possible reasons are […]
Living with a Severe Nut Allergy – Rosie Brandreth-Poynter
20 Nov 2019
Living with a nut allergy, and, subsequently, my little sister’s nut allergy drove my passion for baking, and, ultimately my decision to apply for the Great British Bake Off. When I was five years old, I had an anaphylactic reaction, and was diagnosed with a severe nut allergy. Allergies were a lot less common in […]
EpiPen 0.3mg Auto-Injectors have Longer Shelf Life
15 Nov 2019
EpiPen 0.3mg auto-injector devices have now had their shelf life increased from 20 months to 24 months from the date of manufacture. Expiry dates can be found on the label on the auto-injector device and should not be used after this date. The shelf life for EpiPen 0.15mg auto-injector devices remains at 19 months from […]
25 Years – A Helpline Q&A
31 Oct 2019
The aim of the Anaphylaxis Campaign is to create a safe environment for all people with allergies by working with and educating the food industry, schools, pre-schools, colleges, health professionals and other key audiences. As part of what we offer, we provide a national helpline service for anyone wanting advice or support over the phone, […]
IMPORTANT UPDATE: Extended Use-by Period for Specific Lots of Jext® 150mcg and 300mcg Adrenaline Auto-Injectors
02 Oct 2019
To support and maintain an overall adequate supply, ALK has obtained acceptance from the UK medicines regulator, MHRA, to extend the use of specific lot (batch) numbers of Jext® 150 mcg and Jext® 300 mcg auto-injectors, beyond the labelled expiry date by four months. The affected lot numbers are listed in the link below. Click […]
IMPORTANT UPDATE: Extended Use-by Period for Specific Lots of EpiPen® 0.3mg Adrenaline Auto-Injectors
30 Sep 2019
Mylan UK have obtained acceptance from the MHRA to extend the use of specific lot numbers of EpiPen® 0.3mg auto-injectors, by 4 months beyond the labelled expiry date. The affected lot numbers are listed in the link below. Click here to see the affected lot numbers Important: The extended use only applies to the lots […]